Comprehensive Financial Consultants Institutional, Inc. Pharma Cyte Biotech, Inc. Call Options Transaction History
Comprehensive Financial Consultants Institutional, Inc.
- $291 Million
- Q3 2025
Call Options
0 transactions
| Quarter | Operation | Price Per call | calls change | calls Held | SEC Form |
|---|
Others Institutions Holding PMCB
# of Institutions
30Shares Held
682KCall Options Held
0Put Options Held
0-
Vanguard Group Inc Valley Forge, PA194KShares$180,8350.0% of portfolio
-
Geode Capital Management, LLC Boston, MA127KShares$117,7400.0% of portfolio
-
Ayrton Capital LLC Westport, CT92.1KShares$85,6407.31% of portfolio
-
Equitec Proprietary Markets, LLC82.7KShares$76,9360.09% of portfolio
-
Jim Simons Renaissance Technologies LLC | New York, Ny49.8KShares$46,3140.0% of portfolio
About PharmaCyte Biotech, Inc.
- Ticker PMCB
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 20,750,100
- Market Cap $19.3M
- Description
- PharmaCyte Biotech, Inc., a biotechnology company, focuses on developing and commercializing cellular therapies for cancer, diabetes, and malignant ascites in the United States. Its cellular therapies are developed based on Cell-in-a-Box, a proprietary cellulose-based live cell encapsulation technology used as a platform to treat various types o...